Treatment of Acute Venous Thromboembolism
Copyright © 2020 Elsevier Inc. All rights reserved..
"Acute venous thromboembolism is a common disease seen by nearly all hospitalists. The advent of low molecular weight heparin (LMWH) several decades ago ushered in the era of early hospital discharge and home treatment. More recently, the direct oral anticoagulants (DOACs) have further simplified outpatient treatment and some offer treatment without parenteral therapy. Use of DOACs for cancer-associated venous thromboembolism is emerging and is a welcome evolution of care to spare oncologic patients the burden of daily LMWH injections.".
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:104 |
|---|---|
| Enthalten in: |
The Medical clinics of North America - 104(2020), 4 vom: 06. Juli, Seite 631-646 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nair, Sashi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
12001-79-5 |
|---|
| Anmerkungen: |
Date Completed 17.06.2020 Date Revised 17.06.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.mcna.2020.03.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310847842 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310847842 | ||
| 003 | DE-627 | ||
| 005 | 20231225141000.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mcna.2020.03.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1036.xml |
| 035 | |a (DE-627)NLM310847842 | ||
| 035 | |a (NLM)32505257 | ||
| 035 | |a (PII)S0025-7125(20)30036-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nair, Sashi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of Acute Venous Thromboembolism |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.06.2020 | ||
| 500 | |a Date Revised 17.06.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Inc. All rights reserved. | ||
| 520 | |a "Acute venous thromboembolism is a common disease seen by nearly all hospitalists. The advent of low molecular weight heparin (LMWH) several decades ago ushered in the era of early hospital discharge and home treatment. More recently, the direct oral anticoagulants (DOACs) have further simplified outpatient treatment and some offer treatment without parenteral therapy. Use of DOACs for cancer-associated venous thromboembolism is emerging and is a welcome evolution of care to spare oncologic patients the burden of daily LMWH injections." | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Anticoagulation | |
| 650 | 4 | |a Deep vein thrombosis | |
| 650 | 4 | |a Pulmonary embolism | |
| 650 | 4 | |a Risk stratification | |
| 650 | 4 | |a Thrombolytic | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Heparin, Low-Molecular-Weight |2 NLM | |
| 650 | 7 | |a Vitamin K |2 NLM | |
| 650 | 7 | |a 12001-79-5 |2 NLM | |
| 700 | 1 | |a Garza, Nina |e verfasserin |4 aut | |
| 700 | 1 | |a George, Matt |e verfasserin |4 aut | |
| 700 | 1 | |a Kaatz, Scott |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Medical clinics of North America |d 1945 |g 104(2020), 4 vom: 06. Juli, Seite 631-646 |w (DE-627)NLM000062588 |x 1557-9859 |7 nnns |
| 773 | 1 | 8 | |g volume:104 |g year:2020 |g number:4 |g day:06 |g month:07 |g pages:631-646 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mcna.2020.03.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 104 |j 2020 |e 4 |b 06 |c 07 |h 631-646 | ||